General Dynamics Armament and Technical Products has been awarded $25 million as part of a firm-fixed-price contract by the US Army for the production of Joint Biological Point Detection Systems (JBPDS).
The contract could be worth up to $750 million if options for a total of 1,089 systems are exercised.
Work will be performed at General Dynamics Armament and Technical Products’ new Charlotte, NC, detection and protection production facility and Columbus, Ohio, and is expected to be complete by August, 31, 2009.
Using laser-induced fluorescence, the self-powered JBPDS automatically detects and identifies biological warfare agents (BWA), such as airborne viruses, bacteria and toxins, in air at very low levels.
Its “biosuite” automatically collects and analyses environmental samples and reports identifying information about agents detected, via standard communications systems, to contacts at both local and remote locations.
JBPDS can operate either as a stand-alone unit or it can be networked with other JBPDS units to provide broad area coverage and pinpoint BWA threats.